American Vanguard Corporation

NYSE:AVD Stock Report

Market Cap: US$303.0m

American Vanguard Valuation

Is AVD undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • PM vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of AVD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: AVD ($10.72) is trading below our estimate of fair value ($49.65)

Significantly Below Fair Value: AVD is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for AVD?

Other financial metrics that can be useful for relative valuation.

AVD key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.9x
Enterprise Value/EBITDA13.6x
PEG Ratio1.1x

Price to Earnings Ratio vs Peers

How does AVD's PE Ratio compare to its peers?

The above table shows the PE ratio for AVD vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average26.3x
IPI Intrepid Potash
45.8xn/aUS$256.4m
UAN CVR Partners
4.1xn/aUS$736.7m
BIOX Bioceres Crop Solutions
37.6x37.5%US$840.3m
MULG Muliang Viagoo Technology
17.5xn/aUS$49.1m
AVD American Vanguard
69.4x65.2%US$303.0m

Price-To-Earnings vs Peers: AVD is expensive based on its Price-To-Earnings Ratio (69.4x) compared to the peer average (26.3x).


Price to Earnings Ratio vs Industry

How does AVD's PE Ratio compare vs other companies in the US Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a16.1%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a16.1%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: AVD is expensive based on its Price-To-Earnings Ratio (69.4x) compared to the US Chemicals industry average (19.6x).


Price to Earnings Ratio vs Fair Ratio

What is AVD's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AVD PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio69.4x
Fair PE Ratio38.9x

PM vs Fair Ratio: AVD is expensive based on its Price-To-Earnings Ratio (69.4x) compared to the estimated Fair Price-To-Earnings Ratio (38.9x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst AVD forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$10.54
US$16.00
+51.8%
18.8%US$19.00US$13.00n/a2
Feb ’25US$11.00
US$16.00
+45.5%
18.8%US$19.00US$13.00n/a2
Jan ’25US$10.97
US$15.50
+41.3%
22.6%US$19.00US$12.00n/a2
Dec ’24US$9.99
US$15.50
+55.2%
22.6%US$19.00US$12.00n/a2
Nov ’24US$9.54
US$23.50
+146.3%
10.6%US$26.00US$21.00n/a2
Aug ’24US$18.06
US$29.50
+63.3%
11.9%US$33.00US$26.00n/a2
Jul ’24US$17.87
US$29.50
+65.1%
11.9%US$33.00US$26.00n/a2
Jun ’24US$17.04
US$29.50
+73.1%
11.9%US$33.00US$26.00n/a2
May ’24US$19.31
US$29.50
+52.8%
11.9%US$33.00US$26.00n/a2
Apr ’24US$21.88
US$29.50
+34.8%
11.9%US$33.00US$26.00n/a2
Mar ’24US$20.99
US$29.50
+40.5%
11.9%US$33.00US$26.00n/a2
Feb ’24US$22.59
US$28.00
+23.9%
7.1%US$30.00US$26.00US$11.002
Jan ’24US$21.71
US$28.00
+29.0%
7.1%US$30.00US$26.00US$10.972
Dec ’23US$22.84
US$28.00
+22.6%
7.1%US$30.00US$26.00US$9.992
Nov ’23US$23.47
US$27.50
+17.2%
5.5%US$29.00US$26.00US$9.542
Oct ’23US$18.70
US$27.50
+47.1%
5.5%US$29.00US$26.00US$10.932
Sep ’23US$19.66
US$27.50
+39.9%
5.5%US$29.00US$26.00US$13.762
Aug ’23US$23.63
US$27.50
+16.4%
5.5%US$29.00US$26.00US$18.062
Jul ’23US$22.54
US$27.50
+22.0%
5.5%US$29.00US$26.00US$17.872
Jun ’23US$24.73
US$27.50
+11.2%
5.5%US$29.00US$26.00US$17.042
May ’23US$21.40
US$26.00
+21.5%
7.7%US$28.00US$24.00US$19.312
Apr ’23US$21.11
US$23.50
+11.3%
2.1%US$24.00US$23.00US$21.882
Mar ’23US$14.89
US$23.50
+57.8%
2.1%US$24.00US$23.00US$20.992
Feb ’23US$15.24
US$23.50
+54.2%
2.1%US$24.00US$23.00US$22.592

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies

Price7D1Y
Mkt CapP/EGrowth
Price7D1Y
Mkt CapP/EGrowth
Price7D1Y
Mkt CapP/EGrowth
Price7D1Y
Mkt CapP/EGrowth
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.